• 

  Treatment of the axilla in patients with primary breast cancer and low burden axillary disease: Limitations of the evidence from randomised controlled trials 

  Robertson, JFR; Herrod, PJJ; Matthew, J; Kilburn, LS; Coles, CE; Bradbury, I (Elsevier, 2017-02)

  Invasive breast cancer is the second most common cancer worldwide. It is known to metastasise to the regional axillary lymph nodes but there has been debate over what is the best way to stage and treat the axilla in patients ...
• 

  Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial 

  Coles, CE; Griffin, CL; Kirby, AM; Titley, J; Agrawal, RK; Alhasso, A; Bhattacharya, ISBrunt, AMCiurlionis, LChan, CDonovan, EMEmson, MAHarnett, ANHaviland, JSHopwood, PJefford, MLKaggwa, RSawyer, EJSyndikus, ITsang, YMWheatley, DAWilcox, MYarnold, JRBliss, JM et al.

  Background: Local cancer relapse risk after breast conservation surgery followed by radiotherapy has fallen sharply in many countries, and is influenced by patient age and clinicopathological factors. We hypothesise that ...
• 

  High-resolution structure of the presynaptic RAD51 filament on single-stranded DNA by electron cryo-microscopy 

  Short, JM; Liu, Y; Chen, S; Soni, N; Madhusudhan, MS; Shivji, MKK; Venkitaraman, AR (2016-11-02)
• 

  An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes 

  Mohankumar, KM; Currle, DS; White, E; Boulos, N; Dapper, J; Eden, C; Nimmervoll, BThiruvenkatam, RConnelly, MKranenburg, TANeale, GOlsen, SWang, YDFinkelstein, DWright, KGupta, KEllison, DWThomas, AOGilbertson, RJ et al. (2015-08-30)

View more